D.A. Davidson & Co’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,940
Closed -$187K 1354
2023
Q2
$187K Hold
10,940
﹤0.01% 1245
2023
Q1
$193K Buy
10,940
+794
+8% +$14.4K ﹤0.01% 1235
2022
Q4
$183K Sell
10,146
-257
-2% -$4.76K ﹤0.01% 1207
2022
Q3
$180K Buy
+10,403
New +$199K ﹤0.01% 1175
2017
Q4
Sell
-8,000
Closed -$201K 1120
2017
Q3
$201K Buy
8,000
+1,750
+28% +$44K ﹤0.01% 1013
2017
Q2
$156K Hold
6,250
﹤0.01% 1065
2017
Q1
$150K Hold
6,250
﹤0.01% 1061
2016
Q4
$132K Buy
6,250
+1,000
+19% +$22.3K ﹤0.01% 1179
2016
Q3
$125K Buy
5,250
+300
+6% +$7.54K ﹤0.01% 1146
2016
Q2
$116K Hold
4,950
﹤0.01% 1061
2016
Q1
$118K Hold
4,950
﹤0.01% 1052
2015
Q4
$146K Buy
4,950
+1,700
+52% +$52.5K ﹤0.01% 960
2015
Q3
$89K Buy
3,250
+796
+32% +$27.1K ﹤0.01% 1138
2015
Q2
$85K Hold
2,454
﹤0.01% 1216
2015
Q1
$83K Buy
2,454
+511
+26% +$17.1K ﹤0.01% 1216
2014
Q4
$59K Hold
1,943
﹤0.01% 1364
2014
Q3
$53K Buy
1,943
+1,023
+111% +$27.7K ﹤0.01% 1382
2014
Q2
$23K Buy
+920
New +$24K ﹤0.01% 1616

Other funds holding HQH

D.A. Davidson & Co's HQH Position: Q3 2023 in Review

D.A. Davidson & Co sold out of abrdn Healthcare Investors (HQH) in Q3 2023, closing a stake of 10,940 shares — an estimated $187K sold.

D.A. Davidson & Co first reported a position in HQH in Q2 2014 and held it in 18 quarters. The position peaked at $201K in Q3 2017. 115 funds tracked by Wall St. Rank hold HQH as of Q3 2023.

  • D.A. Davidson & Co reported no remaining abrdn Healthcare Investors position as of Q3 2023 after selling out during the quarter.
  • D.A. Davidson & Co sold 10,940 abrdn Healthcare Investors shares in Q3 2023, an estimated $187K.
  • D.A. Davidson & Co first reported a position in abrdn Healthcare Investors in Q2 2014 and held it in 18 quarters.
  • D.A. Davidson & Co's abrdn Healthcare Investors position peaked at $201K in Q3 2017.
  • 115 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2023.

Based on D.A. Davidson & Co's 13F filing for Q3 2023, filed 8 Nov 2023.